Notably, genetic liability to higher albumin was linked to a reduced risk of severe COVID-19, with an odds ratio (OR) of 0.96 for each SD increase in albumin (95% CI: 0.93–1.00, Table S12). This evidence concerns the gene ALB and COVID-19.